نتایج جستجو برای: interferon beta 1

تعداد نتایج: 2915207  

Journal: :Computational and Mathematical Biophysics 2022

Abstract Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2) infection is a major risk factor for mortality and morbidity in critical care hospitals around the world. Lung epithelial type II cells play role recognition clearance of respiratory viruses as well repair lung injury response to environmental toxicants. Gene expression profiling studies revealed that mouse express several ce...

Background and Objective: Due to the severe inflammatory conditions and cytokine storm in COVID-19 disease, corticosteroids are used worldwide as adjunctive therapy for these patients due to their anti-inflammatory effects. However, due to limited and inconsistent information about the effectiveness of this drug, this study aimed to investigate the benefit of combined use of β-interferon and me...

Journal: :Antimicrobial agents and chemotherapy 1984
L E Rasmussen P T Chen T C Merigan

Five recombinant alpha interferons and two recombinant beta interferons have been tested for their ability to inhibit yields of herpes simplex virus types 1 and 2 and human cytomegalovirus in human embryonic lung cells. All of the alpha species and both of the beta forms (cysteine and serine) were active against the herpesviruses tested in this study. Neither the recombinant alpha nor the recom...

Journal: :Actas dermo-sifiliograficas 2013
E Gutiérrez Paredes R Bella Navarro E Montesinos Villaescusa E Jordá Cuevas

1. Gaines AR, Varricchio F. Interferon beta-1b injection site reactions and necroses. Mult Scler. 1998;4:70. 2. Aguilar G, Serrano C, Carmona M, Linares J, Serrano S. Necrosis cutánea por interferón alfa en paciente con melanoma. Actas Dermosifiliogr. 2006;97:539--42. 3. Beiske AG, Myhr KM. Lipoatrophy: a non-reversible complication of subcutaneous interferon-beta 1a treatment of multiple scler...

Journal: :Lancet 2012
Alasdair J Coles Cary L Twyman Douglas L Arnold Jeffrey A Cohen Christian Confavreux Edward J Fox Hans-Peter Hartung Eva Havrdova Krzysztof W Selmaj Howard L Weiner Tamara Miller Elizabeth Fisher Rupert Sandbrink Stephen L Lake David H Margolin Pedro Oyuela Michael A Panzara D Alastair S Compston

BACKGROUND The anti-CD52 monoclonal antibody alemtuzumab reduces disease activity in previously untreated patients with relapsing-remitting multiple sclerosis. We aimed to assess efficacy and safety of alemtuzumab compared with interferon beta 1a in patients who have relapsed despite first-line treatment. METHODS In our 2 year, rater-masked, randomised controlled phase 3 trial, we enrolled ad...

Journal: :Multiple sclerosis 2011
Magnhild Sandberg-Wollheim Enrica Alteri Margaretha Stam Moraga Gabrielle Kornmann

BACKGROUND Women with multiple sclerosis (MS) are advised to discontinue interferon-beta therapy before trying to conceive. Unplanned pregnancies occur and risks related to exposure remain unclear. METHODS To determine pregnancy outcomes following interferon-beta therapy, we examined pregnancies from a global drug safety database containing individual case safety reports received in the post-...

Journal: :Current Opinion in Endocrine and Metabolic Research 2021

Medical therapy of clinically nonfunctioning (nonsecreting) low grade (grade 1–2) neuroendocrine neoplasms consists first-line first generation somatostatin analogs and second-line or third-line peptide receptor radiotherapy with radiolabeled beta-emitting analogs, Everolimus, Sunitinib, interferon-α. Second-generation like Pasireotide have no proven superiority over first-generation analogs. C...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید